Morepen Laboratories Limited has informed the Exchange regarding 'Intimation of name change from Morepen Medtech Limited to Morepen Medipath Limited , a subsidiary of the Company '.
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Morepen Laboratories has informed the stock exchange about a name change in one of its subsidiaries. The subsidiary, previously called Morepen Medtech Limited, will now be known as Morepen Medipath Limited. This is purely a name change and does not involve any change in ownership, business operations, or financial structure. The rebrand from 'Medtech' to 'Medipath' suggests the subsidiary's focus may be shifting more towards diagnostics and pathology-related services. No new capital infusion, merger, or acquisition is involved in this announcement.
This is a routine corporate announcement about a subsidiary and is unlikely to have any direct impact on Morepen Laboratories' stock price or shareholder value. Investors should note this only as an informational update.